The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
RMD Open
(Dec 2021)
Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritis
Peter Nash,
Luminita Pricop,
Bruce W Kirkham,
Alexis Ogdie,
Effie Pournara,
Christopher T Ritchlin,
Matthias Kormaksson,
Gregory Ligozio
Affiliations
Peter Nash
School of Medicine, Griffith University School of Medicine, Gold Coast, Queensland, Australia
Luminita Pricop
Immunology, Heptatology and Dermatology, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA
Bruce W Kirkham
Rheumatology, Guy`s and St Thomas` NHS Foundation Trust, London, UK
Alexis Ogdie
Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
Effie Pournara
Immunology, Heptatology and Dermatology, Novartis AG, Basel, Switzerland
Christopher T Ritchlin
Department of Medicine, Allergy/Immunology and Rheumatology (SMD), University of Rochester, Rochester, New York, USA
Matthias Kormaksson
Advanced Exploratory Analytics, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA
Gregory Ligozio
Immunology, Heptatology and Dermatology, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA
DOI
https://doi.org/10.1136/rmdopen-2021-001845
Journal volume & issue
Vol. 7, no. 3
Abstract
Read online
No abstracts available.
WeChat QR code
Close